Monitored source Updated every 6h
Pharmaceutical Technology
Pharmaceutical Technology is an industry-news source covering pharma biotech that ScopePlex monitors daily for construction-phase signals. 23 public signals tracked.
Pharmaceutical Technology has contributed 23 public, confidence-scored construction signals tracked by ScopePlex. As an industry-news source, it surfaces pharma biotech construction activity — awards, financings, and groundbreakings — that ScopePlex cross-checks against primary records before a signal is published. For BD teams at specialty contractors, watching this source is one input into knowing which pharma biotech projects are entering the window where subcontract relationships are won — before the formal RFP.
Signals tracked
23
Class
industry news
Type
rss
Related sources in Pharmaceutical & Biotech
Recent public signals from this source
Jul 28
Argenx signs agreement to buy Forte Biosciences for $2.2bn
Jul 24
BeOne to invest $300m in US manufacturing facility expansion
Jul 20
Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal
Jul 16
Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover
Jun 29
Biogen trims Apellis pipeline and R&D team after $5.6bn takeover
Jun 25
RQ Bio secures $115m to develop influenza antibody programme
Jun 17
Altaris to acquire Simulations Plus in $375m all-cash deal
Jun 9
J&J to acquire Firefly Bio for $1bn to enhance oncology pipeline
Jun 4
Regeneron and CytomX extend cancer therapy partnership to $4bn deal
Jun 2
ASCO26: In vivo oncology approaches continue to show promise
Jun 2
Servier to acquire Edgewise’s muscular dystrophy business for $2.65bn
Jun 1
Lilly and Hanmi sign $1.26bn licensing deal for sonefpeglutide
May 21
FUJIFILM opens new iPSC facility in Madison, US
May 19
Regeneron signs $2.32bn deal with Parabilis for Helicon conjugates
May 8
Construction begins on Novartis’ RLT centre in Texas, US
May 8
Angelini Pharma to acquire Catalyst Pharmaceuticals for equity value of $4.1bn
May 7
GSK spends $1bn on rights to SiranBio’s metabolic oligonucleotide
May 7
Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing
May 6
MSD concludes Terns acquisition to expand CML pipeline
May 5
Latus Bio secures $97m in funding to boost gene therapy access
Apr 27
Eli Lilly outlays $2.3bn to acquire blood cancer specialist Ajax Therapeutics
Apr 23
AbbVie opts for North Carolina to house $1.4bn manufacturing site
Apr 23
MSD teams up with Google Cloud on agentic AI transformation
Gated intelligence
The facts are public. The intelligence is behind signup.
- Confidence score on every signal
- "Why it matters" — the BD read on each move
- Timing window & who to call
- Your curated daily brief, filtered to your sectors
- Saved pursuits, company watchlists & alerts
Unlock Pharmaceutical Technology intelligence →7-day trial · no card required